vs
Side-by-side financial comparison of Enpro Inc. (NPO) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.
Enpro Inc. is the larger business by last-quarter revenue ($295.4M vs $37.2M, roughly 7.9× Organogenesis Holdings Inc.). On growth, Enpro Inc. posted the faster year-over-year revenue change (14.3% vs -57.1%). Over the past eight quarters, Enpro Inc.'s revenue compounded faster (7.1% CAGR vs -46.5%).
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
NPO vs ORGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $295.4M | $37.2M |
| Net Profit | $-32.0M | — |
| Gross Margin | 42.1% | 30.8% |
| Operating Margin | 11.2% | -185.1% |
| Net Margin | -10.8% | — |
| Revenue YoY | 14.3% | -57.1% |
| Net Profit YoY | -330.2% | — |
| EPS (diluted) | $-1.50 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $37.2M | ||
| Q4 25 | $295.4M | $225.6M | ||
| Q3 25 | $286.6M | $150.9M | ||
| Q2 25 | $288.1M | $101.0M | ||
| Q1 25 | $273.2M | $86.7M | ||
| Q4 24 | $258.4M | $126.7M | ||
| Q3 24 | $260.9M | $115.2M | ||
| Q2 24 | $271.9M | $130.2M |
| Q1 26 | — | — | ||
| Q4 25 | $-32.0M | $43.7M | ||
| Q3 25 | $21.6M | $21.6M | ||
| Q2 25 | $26.4M | $-9.4M | ||
| Q1 25 | $24.5M | $-18.8M | ||
| Q4 24 | $13.9M | $7.7M | ||
| Q3 24 | $19.8M | $12.3M | ||
| Q2 24 | $26.7M | $-17.0M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | 42.1% | — | ||
| Q3 25 | 41.9% | — | ||
| Q2 25 | 43.3% | — | ||
| Q1 25 | 43.3% | 72.6% | ||
| Q4 24 | 42.3% | 75.5% | ||
| Q3 24 | 42.3% | 76.7% | ||
| Q2 24 | 43.8% | 77.6% |
| Q1 26 | — | -185.1% | ||
| Q4 25 | 11.2% | 28.1% | ||
| Q3 25 | 14.3% | 13.7% | ||
| Q2 25 | 15.9% | -12.5% | ||
| Q1 25 | 15.3% | -30.9% | ||
| Q4 24 | 12.5% | 8.1% | ||
| Q3 24 | 13.1% | 5.4% | ||
| Q2 24 | 17.7% | -10.7% |
| Q1 26 | — | — | ||
| Q4 25 | -10.8% | 19.4% | ||
| Q3 25 | 7.5% | 14.3% | ||
| Q2 25 | 9.2% | -9.3% | ||
| Q1 25 | 9.0% | -21.7% | ||
| Q4 24 | 5.4% | 6.1% | ||
| Q3 24 | 7.6% | 10.7% | ||
| Q2 24 | 9.8% | -13.1% |
| Q1 26 | — | — | ||
| Q4 25 | $-1.50 | $0.31 | ||
| Q3 25 | $1.01 | $0.11 | ||
| Q2 25 | $1.25 | $-0.10 | ||
| Q1 25 | $1.15 | $-0.17 | ||
| Q4 24 | $0.65 | $0.05 | ||
| Q3 24 | $0.94 | $0.09 | ||
| Q2 24 | $1.27 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.7M | $91.4M |
| Total DebtLower is stronger | $655.3M | — |
| Stockholders' EquityBook value | $1.5B | — |
| Total Assets | $2.7B | $520.0M |
| Debt / EquityLower = less leverage | 0.42× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $91.4M | ||
| Q4 25 | $114.7M | $93.7M | ||
| Q3 25 | $132.9M | $63.7M | ||
| Q2 25 | $107.1M | $73.1M | ||
| Q1 25 | $240.3M | $110.0M | ||
| Q4 24 | $236.3M | $135.6M | ||
| Q3 24 | $206.9M | $94.3M | ||
| Q2 24 | $175.9M | $89.9M |
| Q1 26 | — | — | ||
| Q4 25 | $655.3M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $640.1M | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $300.1M | ||
| Q3 25 | $1.5B | $255.1M | ||
| Q2 25 | $1.5B | $233.2M | ||
| Q1 25 | $1.5B | $242.9M | ||
| Q4 24 | $1.4B | $262.9M | ||
| Q3 24 | $1.5B | $278.5M | ||
| Q2 24 | $1.4B | $263.5M |
| Q1 26 | — | $520.0M | ||
| Q4 25 | $2.7B | $598.7M | ||
| Q3 25 | $2.4B | $509.8M | ||
| Q2 25 | $2.4B | $461.1M | ||
| Q1 25 | $2.5B | $467.4M | ||
| Q4 24 | $2.5B | $497.9M | ||
| Q3 24 | $2.5B | $446.3M | ||
| Q2 24 | $2.5B | $443.2M |
| Q1 26 | — | — | ||
| Q4 25 | 0.42× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
ORGO
Segment breakdown not available.
